Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block. Comment on Br J Anaesth 2024; 132 : 45-52
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:132 |
|---|---|
| Enthalten in: |
British journal of anaesthesia - 132(2024), 4 vom: 29. März, Seite 820-821 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Miyazaki, Yusuke [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.03.2024 Date Revised 05.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bja.2024.01.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367860635 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367860635 | ||
| 003 | DE-627 | ||
| 005 | 20240305232258.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240201s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bja.2024.01.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1317.xml |
| 035 | |a (DE-627)NLM367860635 | ||
| 035 | |a (NLM)38296751 | ||
| 035 | |a (PII)S0007-0912(24)00014-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Miyazaki, Yusuke |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block. Comment on Br J Anaesth 2024; 132 |b 45-52 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2024 | ||
| 500 | |a Date Revised 05.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial, Phase III | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a adamgammadex | |
| 650 | 4 | |a adverse drug reaction | |
| 650 | 4 | |a anaphylaxis | |
| 650 | 4 | |a recurarisation | |
| 650 | 4 | |a sugammadex | |
| 650 | 7 | |a Sugammadex |2 NLM | |
| 650 | 7 | |a 361LPM2T56 |2 NLM | |
| 650 | 7 | |a Rocuronium |2 NLM | |
| 650 | 7 | |a WRE554RFEZ |2 NLM | |
| 650 | 7 | |a gamma-Cyclodextrins |2 NLM | |
| 650 | 7 | |a Neuromuscular Nondepolarizing Agents |2 NLM | |
| 650 | 7 | |a Androstanols |2 NLM | |
| 700 | 1 | |a Suzuki, Kaoru |e verfasserin |4 aut | |
| 700 | 1 | |a Sunaga, Hiroshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of anaesthesia |d 1946 |g 132(2024), 4 vom: 29. März, Seite 820-821 |w (DE-627)NLM000000310 |x 1471-6771 |7 nnns |
| 773 | 1 | 8 | |g volume:132 |g year:2024 |g number:4 |g day:29 |g month:03 |g pages:820-821 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bja.2024.01.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 132 |j 2024 |e 4 |b 29 |c 03 |h 820-821 | ||